{
    "2021-09-15": [
        [
            {
                "time": "",
                "original_text": "长春高新：金妥昔单抗与其他相同靶点的抗体相比具有完全不同的分子，在实际药理药效方面也有差异，属于创新药",
                "features": {
                    "keywords": [
                        "长春高新",
                        "金妥昔单抗",
                        "创新药",
                        "分子差异",
                        "药理药效"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}